SalioGen Therapeutics, a company that raised $135 million to develop a new gene-editing technology, has instituted widespread ...

The FDA, in a stark reversal, on Friday said it would reconsider its decision to remove Eli Lilly’s tirzepatide from its ...

There’s a war brewing over blockbuster weight loss medications — and patients are now getting caught in the crossfire.

The men who received this year’s prizes are “superstars,” said Liselotte Jauffred, a physicist at the Niels Bohr Institute ...

Some may argue that the stories of homeless people with vulnerable health I am sharing are just anecdotes, and that sweeping ...

Vice President Kamala Harris is in “excellent health” and “possesses the physical and mental resiliency” required to serve as ...

Kamala Harris’ Medicare at home plan is a good start. But what the U.S. really needs is a gig economy model for elder care.

Six years ago, Sanofi gave $125 million and promised over $1 billion in milestone payments to buzzy neuroscience startup ...

First Opinion is STAT’s platform for interesting, illuminating, and provocative articles about the life sciences writ large, ...

Gold absolutely knew she didn’t want to be a psychiatrist. In this excerpt from “How Do You Feel?” she explains how it ...

The former CEO of Alnylam spoke with STAT about raising money to focus on one big idea, and the prospect for a $100 billion ...

Teva also agreed to pay $25 million to resolve allegations it conspired with other generic drug companies to fix prices for ...